Own governance and execution oversight for drug product-related technology transfers, new product introductions (NPI), and major operational initiatives, integrating Manufacturing, MSAT, Quality, Supply Chain, and Program Management to ensure structured risk management, milestone control, and scalable fill/finish delivery models. Lead end-to-end operational readiness for viral vector drug product and sterile fill/finish operations within a cGMP manufacturing environment, ensuring facility, process, and team preparedness to deliver clinical and commercial batches safely, compliantly, and on schedule.